• Please log in or register to access this feature.
You have free access to this content

The timeline of metalloprotease events during oligofructose induced equine laminitis development

  1. M. B. VISSER*,
  2. C. C. POLLITT

Article first published online: 23 JUN 2011

DOI: 10.1111/j.2042-3306.2011.00393.x

Issue

Equine Veterinary Journal

Equine Veterinary Journal

Volume 44, Issue 1, pages 88–93, January 2012

Additional Information

How to Cite

VISSER, M. B. and POLLITT, C. C. (2012), The timeline of metalloprotease events during oligofructose induced equine laminitis development. Equine Veterinary Journal, 44: 88–93. doi: 10.1111/j.2042-3306.2011.00393.x

Author Information

  1. The Australian Equine Laminitis Research Unit, School of Veterinary Science, The University of Queensland, Australia.

* Email: michelle.visser@utoronto.ca. Present address: Faculty of Dentistry, University of Toronto, 124 Edward St. Toronto, Ontario, Canada M5G 1G6.

Publication History

  1. Issue published online: 1 DEC 2011
  2. Article first published online: 23 JUN 2011
  3. [Paper received for publication 07.12.10; Accepted 04.03.11]

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (571K)

References

  • Bejarano, P.A., Noelken, M.E., Suzuki, K., Hudson, B.G. and Nagase, H. (1988) Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin). Biochem. J. 256, 413-419.
  • Black, S.J., Lunn, D.P., Yin, C., Hwang, M., Lenz, S.D. and Belknap, J.K. (2006) Leukocyte emigration in the early stages of laminitis. Vet. Immunol. Immunopathol. 109, 161-166.
  • Budak, M.T., Orsini, J.A., Pollitt, C.C. and Rubinstein, N.A. (2009) Gene expression in the lamellar dermis-epidermis during the developmental phase of carbohydrate overload-induced laminitis in the horse. Vet. Immunol. Immunopathol. 131, 86-96.
  • Chakraborti, S., Mandal, M., Das, S., Mandal, A. and Chakraborti, T. (2003) Regulation of matrix metalloproteinases: an overview. Mol. Cell. Biochem. 253, 269-285.
  • Clark, I.M., Swingler, T.E., Sampieri, C.L. and Edwards, D.R. (2008) The regulation of matrix metalloproteinases and their inhibitors. Int. J. Biochem. Cell Biol. 40, 1362-1378.
  • Clutterbuck, A.L., Harris, P., Allaway, D. and Mobasheri, A. (2008) Matrix metalloproteinases in inflammatory pathologies of the horse. Vet. J. 187, 27-38.
  • Cowland, J.B. and Borregaard, N. (1999) The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J. Leukoc. Biol. 66, 989-995.
  • Coyne, M.J., Cousin, H., Loftus, J.P., Johnson, P.J., Belknap, J.K., Gradil, C.M., Black, S.J. and Alfandari, D. (2009) Cloning and expression of ADAM-related metalloproteases in equine laminitis. Vet. Immunol. Immunopathol. 129, 231-241.
  • Crabbe, T., Smith, B., O'Connell, J. and Docherty, A. (1994) Human progelatinase A can be activated by matrilysin. FEBS Lett. 345, 14-16.
  • Croser, E. and Pollitt, C. (2006) Acute laminitis: Descriptive evaluation of serial hoof biopsies. Proc. Am. Ass equine Practnrs. 52, 542-546.
  • De la Rebiere de Pouyade, G., Riggs, L.M., Moore, J.N., Franck, T., Deby-Dupont, G., Hurley, D.J. and Serteyn, D. (2009) Equine neutrophil elastase in plasma, laminar tissue, and skin of horses administered black walnut heartwood extract. Vet. Immunol. Immunopathol. 135, 181-187.
  • Hernandez-Barrantes, S., Bernardo, M., Toth, M. and Fridman, R. (2002) Regulation of membrane type-matrix metalloproteinases. Semin. Cancer Biol. 12, 131-138.
  • Johnson, P.J., Tyagi, S.C., Katwa, L.C., Ganjam, V.K., Moore, L.A., Kreeger, J.M. and Messer, N.T. (1998) Activation of extracellular matrix metalloproteinases in equine laminitis. Vet. Rec. 142, 392-396.
  • Jones, G.C. and Riley, G.P. (2005) ADAMTS proteinases: A multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis. Arthritis Res. Ther. 7, 160-169.
  • Kashiwagi, M., Tortorella, M., Nagase, H. and Brew, K. (2001) TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J. Biol. Chem. 276, 12501-12504.
  • Kessenbrock, K., Plaks, V. and Werb, Z. (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67.
  • Kyaw-Tanner, M. and Pollitt, C.C. (2004) Equine laminitis: increased transcription of matrix metalloproteinase-2 (MMP-2) occurs during the developmental phase. Equine vet. J. 36, 221-225.
    Direct Link:
  • Kyaw-Tanner, M.T., Wattle, O., van Eps, A.W. and Pollitt, C.C. (2008) Equine laminitis: Membrane type matrix metalloproteinase-1 (MMP-14) is involved in acute phase onset. Equine vet. J. 40, 482-487.
    Direct Link:
  • Lambert, E., Dasse, E., Haye, B. and Petitfrere, E. (2004) TIMPs as multifacial proteins. Crit. Rev. Oncol. Hematol. 49, 187-198.
  • Lauer-Fields, J.L., Minond, D., Sritharan, T., Kashiwagi, M., Nagase, H. and Fields, G.B. (2007) Substrate conformation modulates aggrecanase (ADAMTS-4) affinity and sequence specificity. Suggestion of a common topological specificity for functionally diverse proteases. J. Biol. Chem. 282, 142-150.
  • Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25, 402-408.
  • Loftus, J.P., Belknap, J.K. and Black, S.J. (2006) Matrix metalloproteinase-9 in laminae of black walnut extract treated horses correlates with neutrophil abundance. Vet. Immunol. Immunopathol. 113, 267-276.
  • Loftus, J., Johnson, P., Yin, C., Belknap, J. and Black, S. (2008) Matrix metalloproteinases and structural tissue damage in equine laminitis. In: American College of Veterinary Internal Medicine, San Antonio.
  • Loftus, J.P., Black, S.J., Pettigrew, A., Abrahamsen, E.J. and Belknap, J.K. (2007) Early laminar events involving endothelial activation in horses with black walnut- induced laminitis. Am. J. vet. Res. 68, 1205-1211.
  • Loftus, J.P., Johnson, P.J., Belknap, J.K., Pettigrew, A. and Black, S.J. (2009) Leukocyte-derived and endogenous matrix metalloproteinases in the lamellae of horses with naturally acquired and experimentally induced laminitis. Vet. Immunol. Immunopathol. 129, 221-230.
  • Milinovich, G.J., Trott, D.J., Burrell, P.C., Croser, E.L., Al Jassim, R.A., Morton, J.M., van Eps, A.W. and Pollitt, C.C. (2007) Fluorescence in situ hybridization analysis of hindgut bacteria associated with the development of equine laminitis. Environ. Microbiol. 9, 2090-2100.
    Direct Link:
  • Morrison, C.J., Butler, G.S., Bigg, H.F., Roberts, C.R., Soloway, P.D. and Overall, C.M. (2001) Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway. J. Biol. Chem. 276, 47402-47410.
  • Mungall, B.A. and Pollitt, C.C. (1999) Zymographic analysis of equine laminitis. Histochem. Cell Biol. 112, 467-472.
  • Nakamura, H., Fujii, Y., Inoki, I., Sugimoto, K., Tanzawa, K., Matsuki, H., Miura, R., Yamaguchi, Y. and Okada, Y. (2000) Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. J. Biol. Chem. 275, 38885-38890.
  • Nie, J. and Pei, D. (2003) Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond. Cancer Res. 63, 6758-6762.
  • Noschka, E., Vandenplas, M.L., Hurley, D.J. and Moore, J.N. (2009) Temporal aspects of laminar gene expression during the developmental stages of equine laminitis. Vet. Immunol. Immunopathol. 129, 242-253.
  • Obel, N. (1948) Studies on the Histopathology of Acute Laminitis, Almqvist & Wiksells Boktryckeri AB, Stockholm.
  • Owen, C.A. (2008) Leukocyte cell surface proteinases: regulation of expression, functions, and mechanisms of surface localization. Int. J. Biochem. Cell Biol. 40, 1246-1272.
  • Pawlak, E., Wang, L., Alfandari, D., Johnson, P.J., Belknap, J.K. and Black, S.J. (2009) Localization and function of sulfated proteoglycans in the equine digital laminae. In: Proceedings of the Second AAEP Foundation Equine Laminitis Research Workshop, West Palm Beach.
  • Pirila, E., Sharabi, A., Salo, T., Quaranta, V., Tu, H., Heljasvaara, R., Koshikawa, N., Sorsa, T. and Maisi, P. (2003) Matrix metalloproteinases process the laminin-5 gamma 2-chain and regulate epithelial cell migration. Biochem. Biophys. Res. Commun. 303, 1012-1017.
  • Pollitt, C.C. (1996) Basement membrane pathology: A feature of acute equine laminitis. Equine vet J. 28, 38-46.
    Direct Link:
  • Pollitt, C.C. (2010) The anatomy and physiology of the suspensory apparatus of the distal phalanx. Vet. Clin. N. Am.: Equine Pract. 26, 29-49.
  • Pollitt, C.C. and Daradka, M. (1998) Equine laminitis basement membrane pathology: loss of type IV collagen, type VII collagen and laminin immunostaining. Equine vet. J., Suppl. 26, 139-144.
  • Pollitt, C.C., Pass, M.A. and Pollitt, S. (1998) Batimastat (BB-94) inhibits matrix metalloproteinases of equine laminitis. Equine vet. J., Suppl. 26, 119-124.
  • Sambrook, J., Fritsch, E. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn., Cold Spring Harbour Laboratory Press, Cold Spring Harbor.
  • Sternlicht, M.D. and Werb, Z. (2001) How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516.
  • Tortorella, M.D., Burn, T.C., Pratta, M.A., Abbaszade, I., Hollis, J.M., Liu, R., Rosenfeld, S.A., Copeland, R.A., Decicco, C.P., Wynn, R., Rockwell, A., Yang, F., Duke, J.L., Solomon, K., George, H., Bruckner, R., Nagase, H., Itoh, Y., Ellis, D.M., Ross, H., Wiswall, B.H., Murphy, K., Hillman, M.C., Jr, Hollis, G.F., Newton, R.C., Magolda, R.L., Trzaskos, J.M. and Arner, E.C. (1999) Purification and cloning of aggrecanase-1: A member of the ADAMTS family of proteins. Science 284, 1664-1666.
  • van Eps, A.W. and Pollitt, C.C. (2006) Equine laminitis induced with oligofructose. Equine vet. J. 38, 203-208.
    Direct Link:
  • Visse, R. and Nagase, H. (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ. Res. 92, 827-839.
  • Visser, M.B. (2009) Investigation of Proteolysis of the Basement Membrane during the Development of Equine Laminitis, The University of Queensland, Brisbane.
  • Visser, M.B. and Pollitt, C.C. (2011) The timeline of lamellar basement membrane changes during equine laminitis development. Equine vet. J. 43, 471-477.
    Direct Link:
  • Wang, J., Lelse, B., Gustafson, A., Nanduri, B., Belknap, J.K. and Chowdhary, B. (2009a) Genome-wide transcriptome profiling of laminar tissue during early stages of carbohydrate overload-induced equine laminitis. In: Proceedings of the Second AAEP Foundation Equine Laminitis Research Workshop, West Palm Beach.
  • Wang, L., Pawlak, E., Alfandari, D., Johnson, P.J., Belknap, J.K. and Black, S.J. (2009b) Gene and protein expression of polysulfated proteoglycan ECM components in the equine digital lamellae. In: Proceedings of the Second AAEP Foundation Equine Laminitis Research Workshop, West Palm Beach.
  • Wang, F.Q., So, J., Reierstad, S. and Fishman, D.A. (2005) Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase. Int. J. Cancer 114, 19-31.
    Direct Link:
  • Westling, J., Gottschall, P.E., Thompson, V.P., Cockburn, A., Perides, G., Zimmermann, D.R. and Sandy, J.D. (2004) ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein. Biochem. J. 377, 787-795.
  • Zhao, H., Bernardo, M.M., Osenkowski, P., Sohail, A., Pei, D., Nagase, H., Kashiwagi, M., Soloway, P.D., DeClerck, Y.A. and Fridman, R. (2004) Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation. J. Biol. Chem. 279, 8592-8601.
View Full Article (HTML) Get PDF (571K)